Genentech

Roche’s Ocrevus Shines in Relapsing-Remitting MS, Safety Studies
BioSpace
Thu, 11/3/22 - 07:28 pm
Genentech
Roche
Ocrevus
MS
Relapsing Remitting Multiple Sclerosis
Roche's Vabysmo lands clinical counterpunch in ophthalmology brawl with Eylea
Fierce Pharma
Thu, 10/27/22 - 11:02 am
Roche
Genentech
Vabysmo
bispecific antibodies
Eylea
Ex-Genentech scientist sentenced to six months in prison for stealing trade secrets
Endpoints
Tue, 10/25/22 - 10:50 am
Genentech
trade secrets
ArsenalBio lands $70M cash deal with cancer giant Genentech to develop cell therapy
Endpoints
Tue, 09/27/22 - 10:30 am
ArsenalBio
Genentech
New Genentech Bay Area lab to speed up biologic drug manufacturing with less energy cost
ABC7 News
Wed, 08/31/22 - 10:21 am
Genentech
drug manufacturing
Bay Area
California
San Francisco
China's Jemincare nabs $650M biobucks pact with Roche's Genentech for prostate cancer hopeful
Fierce Biotech
Thu, 08/18/22 - 12:36 pm
Roche
Genentech
China
Jemincare
biobucks
prostate cancer
FDA approves Genentech’s sNDA for influenza therapy in children
Pharmaceutical Business Review
Fri, 08/12/22 - 10:19 am
Genentech
Xofluza
FDA
pediatric
Flu
Roche, Genentech sign license deal with Kiniksa for vixarelimab
Pharmaceutical Business Review
Thu, 08/4/22 - 10:54 am
Kiniksa Pharmaceuticals
Roche
Genentech
vixarelimab
monoclonal antibodies
Little biotech developing Genentech castoff drug hits hurdle in glioblastoma platform trial
Endpoints
Tue, 08/2/22 - 10:35 am
Kazia Therapeutics
paxalisib
Genentech
glioblastoma
Genentech rides up to 2nd target in Bicycle immuno-oncology collab
Fierce Biotech
Tue, 07/12/22 - 10:52 am
Genentech
Bicycle Therapeutics
Roche
immuno-oncology
Fierce NextGen: Despite another key trial failure, Alzheimer's therapy developers find reason for optimism
Fierce Biotech
Wed, 06/29/22 - 10:59 am
Alzheimer's disease
clinical trials
crenezumab
Roche
Genentech
Wipeout: Roche's anti-amyloid attack on presymptomatic Alzheimer's ends in failure
Fierce Biotech
Thu, 06/16/22 - 10:40 am
Roche
Genentech
Alzheimer's disease
crenezumab
New Three-Year Data for Genentech’s Evrysdi (risdiplam) Show Long-Term Improvements in Survival and Motor Milestones in Babies With Type 1 Spinal Muscular Atrophy (SMA)
BioSpace
Fri, 04/29/22 - 10:30 am
Genentech
Evrysdi
risdiplam
SMA
spinal muscular atrophy
Roche Wakes Up to New Competition as FDA Approves Amneal’s Avastin Biosimilar
BioSpace
Thu, 04/14/22 - 10:57 am
Amneal
FDA
bevacizumab-maly
Genentech
Roche
Avastin
biosimilars
20 years in, Genentech persists and perseveres in Alzheimer's with gantenerumab
Fierce Biotech
Wed, 04/6/22 - 07:44 pm
Roche
Genentech
Alzheimer's disease
gantenerumab
JHL's Judas Kiss: an Inside Look at JHL Biotech's Theft from Genentech
BioSpace
Fri, 03/18/22 - 10:44 am
JHL Biotech
Genentech
Roche
trade secrets
Rituxan
Former CEO And COO Of JHL Biotech Sentenced For Conspiring To Steal Trade Secrets And Commit Wire Fraud Exceeding $101 Million
DOJ
Wed, 03/16/22 - 10:12 am
trade secrets
wire fraud
JHL Biotech
Genentech
Aiming to drug genetic modifiers, Roche-partnered biotech bags $31M to fuel a drive toward clinic
Endpoints
Thu, 03/10/22 - 10:27 am
Scenic Biotech
Roche
Genentech
genetic modifiers
Roche adds to Genentech's ophthalmology program with $670M in biobucks for Lineage Cell Therapeutics' asset
Fierce Biotech
Mon, 12/20/21 - 11:32 pm
Roche
Genentech
Lineage Cell Therapeutics
cell therapy
dry age-related macular degeneration
ASH: Roche's antibody-drug conjugate Polivy added to chemo-antibody combo boosts survival in early-stage lymphoma
Endpoints
Tue, 12/14/21 - 11:12 am
ASH2021
Roche
antibody-drug conjugate
Polivy
Genentech
blood cancers

Pages